Altered response to vasopressors before and during cardiopulmonary bypass. 1989

A Baraka

UI MeSH Term Description Entries
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

A Baraka
May 1987, American journal of clinical pathology,
A Baraka
January 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
A Baraka
December 1981, Clinical pharmacology and therapeutics,
A Baraka
May 1984, Clinical pharmacology and therapeutics,
A Baraka
January 1985, International journal of clinical pharmacology research,
A Baraka
July 1979, Clinical pharmacology and therapeutics,
A Baraka
January 1971, Surgical forum,
A Baraka
December 1982, Acta anaesthesiologica Scandinavica,
A Baraka
March 1994, Anesthesiology,
A Baraka
March 1994, Anesthesiology,
Copied contents to your clipboard!